“Media studies describe it as a loophole,” claims Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s extremely intentional coverage.” Brunner has expressed stress regarding how some coverage from the increase of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medicines or research peptides with credentialed functions https://geoffreyr487rsp4.oblogation.com/profile